110353 «2027»
: It is strictly contraindicated in children under 12 years of age and in children under 18 following surgeries like tonsillectomies due to the risk of fatal respiratory depression.
: Allergy, cold, and cough remedy; antitussive. 110353
: Acts directly on the cough center in the brain to suppress the cough reflex. Key Assessment & Safety Monitoring : It is strictly contraindicated in children under
: It should not be used concurrently with MAO inhibitors or within 14 days of stopping them. Key Assessment & Safety Monitoring : It should
: Works by antagonizing the effects of histamine at H1cap H sub 1
Topic is a reference number for the drug Chlorpheniramine Polistirex/Codeine Polistirex , better known by its trade name Tuxarin ER . This extended-release medication is primarily used for the relief of cough and upper respiratory symptoms associated with allergies or the common cold. Therapeutic and Pharmacologic Classification
: A thorough assessment of the risk for opioid addiction, abuse, or misuse must be conducted prior to starting therapy.
: It is strictly contraindicated in children under 12 years of age and in children under 18 following surgeries like tonsillectomies due to the risk of fatal respiratory depression.
: Allergy, cold, and cough remedy; antitussive.
: Acts directly on the cough center in the brain to suppress the cough reflex. Key Assessment & Safety Monitoring
: It should not be used concurrently with MAO inhibitors or within 14 days of stopping them.
: Works by antagonizing the effects of histamine at H1cap H sub 1
Topic is a reference number for the drug Chlorpheniramine Polistirex/Codeine Polistirex , better known by its trade name Tuxarin ER . This extended-release medication is primarily used for the relief of cough and upper respiratory symptoms associated with allergies or the common cold. Therapeutic and Pharmacologic Classification
: A thorough assessment of the risk for opioid addiction, abuse, or misuse must be conducted prior to starting therapy.
